Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Fautrel

Showing results (121-130 of 370) with videos related to

Pageof 37
Sort By:
The Journal of Rheumatology|July 3, 2017
Adherence to Antitumor Necrosis Factor Use Recommendations in Spondyloarthritis: Measurement and Effect in the DESIR CohortStephanie Harvard, Daphne Guh, Nick Bansback, et al.
Rheumatology (Oxford, England)|December 29, 2016
Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologistsMonika Hifinger, Mickael Hiligsmann, Sofia Ramiro, et al.
RMD Open|June 8, 2021
Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effectsJosef S Smolen, Roberto Caporali, Thomas Doerner, et al.
Arthritis Research & Therapy|November 16, 2019
Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohortCédric Lukas, Julia Mary, Michel Debandt, et al.
Joint Bone Spine|March 13, 2024
Entering functional restoration programs for chronic low back pain is delayed when patients do not receive support at work: A study of 185 patients in FranceLaetitia Marson, Sabrina Dadoun, Fanny Roure, et al.
Best Practice & Research. Clinical Rheumatology|December 11, 2012
Impact of co-morbidities on measuring indirect utility by the Medical Outcomes Study Short Form 6D in lower-limb osteoarthritisKossar Hosseini, Cécile Gaujoux-Viala, Joel Coste, et al.
Rheumatology (Oxford, England)|July 28, 2021
How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohortElena Nikiphorou, Annelies Boonen, Bruno Fautrel, et al.
Advances in Therapy|July 28, 2025
Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)Hubert Marotte, Alain Cantagrel, Fabienne Coury, et al.
The Journal of Rheumatology|February 5, 2005
What is the impact of adolescent arthritis and rheumatism? Evidence from a national sample of CanadiansViviane Adam, Yvan St-Pierre, Bruno Fautrel, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 6, 2019
Impact of comorbidities and functional impairment on 5-year loss of health utility in patients with lower-limb osteoarthritis in the KHOALA cohortAbdou Y Omorou, Hamza Achit, Maud Wieczorek, et al.
Pageof 37

Showing results (121-130 of 370) with videos related to

Sort By:
Pageof 37
The Journal of Rheumatology|July 3, 2017
Adherence to Antitumor Necrosis Factor Use Recommendations in Spondyloarthritis: Measurement and Effect in the DESIR CohortStephanie Harvard, Daphne Guh, Nick Bansback, et al.
Rheumatology (Oxford, England)|December 29, 2016
Patients' preferences and economic considerations play an important role in treatment decisions: a discrete choice experiment among rheumatologistsMonika Hifinger, Mickael Hiligsmann, Sofia Ramiro, et al.
RMD Open|June 8, 2021
Treatment journey in rheumatoid arthritis with biosimilars: from better access to good disease control through cost savings and prevention of nocebo effectsJosef S Smolen, Roberto Caporali, Thomas Doerner, et al.
Arthritis Research & Therapy|November 16, 2019
Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohortCédric Lukas, Julia Mary, Michel Debandt, et al.
Joint Bone Spine|March 13, 2024
Entering functional restoration programs for chronic low back pain is delayed when patients do not receive support at work: A study of 185 patients in FranceLaetitia Marson, Sabrina Dadoun, Fanny Roure, et al.
Best Practice & Research. Clinical Rheumatology|December 11, 2012
Impact of co-morbidities on measuring indirect utility by the Medical Outcomes Study Short Form 6D in lower-limb osteoarthritisKossar Hosseini, Cécile Gaujoux-Viala, Joel Coste, et al.
Rheumatology (Oxford, England)|July 28, 2021
How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohortElena Nikiphorou, Annelies Boonen, Bruno Fautrel, et al.
Advances in Therapy|July 28, 2025
Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)Hubert Marotte, Alain Cantagrel, Fabienne Coury, et al.
The Journal of Rheumatology|February 5, 2005
What is the impact of adolescent arthritis and rheumatism? Evidence from a national sample of CanadiansViviane Adam, Yvan St-Pierre, Bruno Fautrel, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 6, 2019
Impact of comorbidities and functional impairment on 5-year loss of health utility in patients with lower-limb osteoarthritis in the KHOALA cohortAbdou Y Omorou, Hamza Achit, Maud Wieczorek, et al.
Pageof 37